# Neuroskin Forte for Dry Skin Relief in Eczema and Psoriasis

> **NCT00143819** · PHASE2 · TERMINATED · sponsor: **University of Medicine and Dentistry of New Jersey** · enrollment: 13 (actual)

## Conditions studied

- Psoriasis
- Eczema

## Interventions

- **DRUG:** Neuroskin Forte
- **DRUG:** Placebo Application

## Key facts

- **NCT ID:** NCT00143819
- **Lead sponsor:** University of Medicine and Dentistry of New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-09
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Low enrollment
- **Last updated:** 2017-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00143819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00143819, "Neuroskin Forte for Dry Skin Relief in Eczema and Psoriasis". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00143819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*